Comprehensive molecular analysis of phase II trial of nivolumab in patients with recurrent or metastatic carcinosarcomas.
Analysis of CA9 and PSMA expression in clear cell renal cell carcinoma (ccRCC) and the effect of prior therapies. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results